News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

University of Montana
|
March 20, 2024

Doug Brinkerhoff intends to use computer deep learning to improve predictions of sea level rise from melting ice sheets. Beverly Piggott will study how brain cells regulate their own acidity during development.

A team of scientists from Montana State University recently published unique research examining how individual cells respond to viral infection. The work used state-of-the-art technology to culture cells and track infection in real time; it is the first known project to use microfluidic technology to culture, infect and track infection on a single-cell level. 

A Montana State University researcher was recently awarded a $2.76 million, five-year grant from the National Institutes of Health to help find pre-symptom evidence of the onset of osteoarthritis, a disease that affects one in seven Americans. 

Wintermute Biomedical has successfully raised USD 1.3 million from investors to propel its groundbreaking Shingles treatment, Solexan™, into a Phase Ib clinical trial. The primary focus of this randomized double-blind placebo-controlled trial is to assess the safety, tolerability, and proof-of-concept efficacy of Solexan™ in reducing shingles-related pain and expediting lesion healing.

Golden Helix
|
February 29, 2024

Golden Helix, Inc. announced that it has received the certification for ISO 13485:2016 from TÜV SÜD. ISO 13485:2016 is an international standard that specifies requirements for a quality management system (QMS) for organizations involved in the design, development, production, and servicing of medical devices. 

ARTICLES OF INTEREST

National Institutes of Health
|
March 26, 2024

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

BIO.News
|
January 30, 2024

As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.

NIH National Institute on Aging
|
January 18, 2024

Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR

National Institutes of Health SEED
|
January 18, 2024

Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.

National Institutes of Health
|
January 14, 2024

Updates from product development and small business programs

NEWSLETTER

Newsletter
|
February 20, 2024

View the Winter II 2024 Newsletter now!

Newsletter
|
December 21, 2023

View the Winter 2023 Newsletter now!